|
HRKorea |
¹ÙÀÌ¿À»ç¾÷°³¹ß:¹ÙÀÌ¿À½Å¾à ÆÄÆ®³Ê½± ¹ß±¼ ¹× È®º¸(ÇØ¿Ü ¹×
¼¿ï ÀüÁö¿ª | ´ëÇпø(¼®»ç) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
3³â¡è |
ä¿ë½Ã |
06.15 |
|
|
´õ ÈÞ¸Õ |
±¹³» À¯¸í»óÀåÁ¦¾à»ç Medical¸¶ÄÉÆÃPM (5~13³âÂ÷) ASAP
¼¿ï Á¾·Î±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
5³â¡è |
ä¿ë½Ã |
06.18 |
|
|
³ª¿ìÆÊÄÁ¼³Æà |
»óÀå Áß°ßÁ¦¾à»ç ƯÇã¾÷¹« °æ·ÂÀÚ ¸ðÁý
¼¿ï °µ¿±¸ | Çз¹«°ü |
°³¹ß/RA/´ë°ü |
°æ·Â¹«°ü |
ä¿ë½Ã |
05.14 |
|
|
¾Æµ¥ÄÚÄÚ¸®¾Æ |
[ÀÇ·á±â±â ¹× ÀǾàÇ° ÄÁ¼³ÆÃ] RA manager
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
7³â¡è |
ä¿ë½Ã |
07.11 |
|
|
³ª¿ìÆÊÄÁ¼³Æà |
¿ÜÀÚ°è -MA ¾÷¹«
¼¿ï ÀüÁö¿ª | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
10.24 |
|
|
³ª¿ìÆÊÄÁ¼³Æà |
»óÀå´ë±â¾÷ ¶óÀ̼¾½Ì BD ¸ðÁý
¼¿ï °³²±¸ | Çз¹«°ü |
°³¹ß/RA/´ë°ü |
°æ·Â¹«°ü |
ä¿ë½Ã |
08.03 |
|
|
³ª¿ìÆÊÄÁ¼³Æà |
Áß°ßÁ¦¾à»ç Á¦Á¦¿¬±¸,Scale-up and Post Approval Changes
¼¿ï ÀüÁö¿ª | Çз¹«°ü |
¿¬±¸/¿¬±¸±âȹ |
°æ·Â¹«°ü |
ä¿ë½Ã |
12.18 |
|
|
³ª¿ìÆÊÄÁ¼³Æà |
ÀǾàÇ° µµ¸Å¾÷ ´ë±â¾÷-OTC,°Ç½Äµî °³¹ß¾÷¹«
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
5³â¡è |
ä¿ë½Ã |
03.17 |
|
|
Ä¿¸®¾îÄɾî |
À¯·´°è Á¦¾àȸ»ç CRA
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
3³â¡è |
ä¿ë½Ã |
06.25 |
|
|
³ª¿ìÆÊÄÁ¼³Æà |
¼öÀÔÀǾàÇ°»ç µ¿¹°¾àÇ° °³¹ßÁ÷ ¸ðÁý
¼¿ï ÀüÁö¿ª | Çз¹«°ü |
Çмú/±³À°/»ó´ã |
°æ·Â¹«°ü |
ä¿ë½Ã |
03.27 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
»ç¾÷°³¹ß½ÇÆÀÀå(Business Development Team Leader)/±¹³»À¯
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¶óÀ̼¾½ºIn/Out |
7³â¡è |
ä¿ë½Ã |
10.29 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
»ç¾÷°³¹ß½ÇÆÀÀå(Business Development Team Leader)/±¹³»À¯
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¶óÀ̼¾½ºIn/Out |
7³â¡è |
ä¿ë½Ã |
09.24 |
|
|
(ÁÖ)¶ó¿Â¼Ä¡ |
±×·ìÁ¦¾à»ç - ÀÓ»ó°³¹ß(Clinical Development) °æ·ÂÀÚ
°æ±â ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
4³â¡è |
ä¿ë½Ã |
07.14 |
|
|
³ª¿ìÆÊÄÁ¼³Æà |
À¯¸Á CRO»ç ÀÓ»ó¾÷¹« °æ·ÂÀÚ ¸ðÁý
¼¿ï ÀüÁö¿ª | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
05.03 |
|
|
³ª¿ìÆÊÄÁ¼³Æà |
»óÀ§CRO»ç-PM ¾÷¹«
¼¿ï ÀüÁö¿ª | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
11.04 |
|